Influence of brain metastases on the classification, treatment, and outcome of patients with extracranial oligometastasis: a single-center cross-sectional analysis

In patients with brain metastases, a low total tumor burden with an oligometastatic disease state remained a significant prognostic factor for overall survival. Presence of brain metastases should therefore not serve as exclusion criterion for clinical trials in the field of oligometastatic disease. Moreover, it underscores the importance of considering a multimodality treatment strategy in oligometastatic cancer patients.

Authors

Institutions

Publication Details

Journal
Radiation Oncology
Published
2024-10-27
DOI
https://doi.org/10.1186/s13014-024-02542-2
Citations
4
Primary Topic
Brain Metastases and Treatment
Type
article
Field-Weighted Citation Impact
1.68

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Influence of brain metastases on the classification, treatment, and outcome of patients with extracranial oligometastasis: a single-center cross-sectional analysis

Michael Weller, Matthias Gückenberger, Philip Heesen, Josef A. Buchner et al.
4 citations
Radiation Oncology
Brain Metastases and Treatment
1.68
article

Influence of brain metastases on the classification, treatment, and outcome of patients with extracranial oligometastasis: a single-center cross-sectional analysis

Michael Weller, Matthias Gückenberger, Philip Heesen, Josef A. Buchner, Sebastian M. Christ, Martin William Huellner, Ayal A. Aizer, Siyer Roohani, Rifaquat Rahman, Nicolaus Andratschke, Maiwand Ahmadsei, Gabriel W. Thiel, Jonas Willmann, Jan Caspar Peeken, Émilie Le Rhun, Urs J. Muehlematter, Michael Mayinger, Alexander Maurer
article en
4 citations

Abstract

In patients with brain metastases, a low total tumor burden with an oligometastatic disease state remained a significant prognostic factor for overall survival. Presence of brain metastases should therefore not serve as exclusion criterion for clinical trials in the field of oligometastatic disease. Moreover, it underscores the importance of considering a multimodality treatment strategy in oligometastatic cancer patients.

Radiation OncologyVol. 19(1)
Brigham and Women's Hospital (US), University of Zurich (CH), TUM Klinikum (DE), Humboldt-Universität zu Berlin (DE), University Hospital of Zurich (CH), Dana-Farber Cancer Institute (US), Dana-Farber Brigham Cancer Center (US), Technical University of Munich (DE), Freie Universität Berlin (DE), Charité - Universitätsmedizin Berlin (DE)
Schweizerische Akademie der Medizinischen Wissenschaften
Good health and well-being
Openalex Percentile: Top 15%
Brain Metastases and Treatment
1.68
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.